Through
5/7
Boris Striepen of Penn Vet organized the First Biennial Cryptosporidium Meeting, bringing together researchers and clinicians from around the world to discuss the problems and progress around the parasite and the diarrheal disease it causes.
Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
A new collaborative study with Penn Vet researchers analyzed fecal samples to shed light on how the fatal disease impacts the gut microbiome in deer, providing a promising tool for disease surveillance.
As the country’s life expectancy has risen, the Malawi Longitudinal Study of Families and Health has shifted its current and future research to aging.
A Penn Medicine study finds that even modest increases in out-of-pocket costs for HIV prevention drugs could double the rate at which prescriptions go unfilled.
Letícia Marteleto, a social demographer new to Penn, does research at the intersection of fertility, Zika, COVID-19, climate conditions, urbanicity, and inequality.
Gov. Josh Shapiro, President Liz Magill, and others from the University community celebrated the new home of the Penn Institute for RNA Innovation.
Two new studies led by Phillip Scott of the School of Veterinary Medicine and Elizabeth Grice of the Perelman School of Medicine demonstrate how bacteria found in leishmaniasis skin lesions and an associated immune response drive disease burden and treatment failure—and suggest new possibilities for treatment of the parasitic disease.
LDI fellows are working with local communities to increase PrEP use through improving the message about the drug, reducing stigma, and normalizing the conversation about HIV infection.
In a new review, Presidential Assistant Professor Cesar de la Fuente and co-authors assess the progress, limitations, and promise of research in AI and infectious diseases.
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
“Tell Me When It’s Over,” a new book by Paul Offit of the Perelman School of Medicine, chronicles the initial years of the COVID-19 pandemic and the mishaps of public health agencies. Recent surveys by the Annenberg Public Policy Center find that mistrust of vaccines has continued to grow through last fall.
FULL STORY →
According to the University of Pennsylvania Health System, flu symptoms usually appear two to three days after contact with the virus.
FULL STORY →
Paul Offit of the Perelman School of Medicine explains why measles is so much more infectious than flu.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize for mRNA vaccines along with Katalin Karikó, is researching an mRNA vaccine against cancer.
FULL STORY →